SEI Investments’s Lisata Therapeutics LSTA Stock Holding History

SEI Investments’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3	Closed	–	–	3312
2017 Q2	$0	Buy	+3	New	+$212	﹤0.01%	3201

Other funds holding LSTA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SEI Investments's LSTA Position: Q3 2017 in Review

SEI Investments sold out of Lisata Therapeutics (LSTA) in Q3 2017, closing a stake of 3 shares.

SEI Investments first reported a position in LSTA in Q2 2017 and held it in 1 quarter. The position peaked at $0 in Q2 2017. 23 funds tracked by Wall St. Rank hold LSTA as of Q3 2017.

SEI Investments reported no remaining Lisata Therapeutics position as of Q3 2017 after selling out during the quarter.
SEI Investments sold 3 Lisata Therapeutics shares in Q3 2017.
SEI Investments first reported a position in Lisata Therapeutics in Q2 2017 and held it in 1 quarter.
SEI Investments's Lisata Therapeutics position peaked at $0 in Q2 2017.
23 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2017.

Based on SEI Investments's 13F filing for Q3 2017, filed 6 Nov 2017.